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Recent reports show an increased occurrence of kidney stone
disease worldwide. To further evaluate and quantify this
observation, we examined recent trends in the incidence
of kidney stone disease in the adult population of Iceland
over a 24-year period. Computerized databases of all major
hospitals and medical imaging centers in Iceland were
searched for International Classification of Diseases,
radiologic and surgical procedure codes indicative of kidney
stones in patients aged 18 years and older. The time trends in
stone frequency of 5945 incident patients (63% men) were
assessed by Poisson regression analysis. The majority of
patients (90.5%) had symptomatic stone disease. The total
incidence of kidney stones rose significantly from 108 per
100,000 in the first 5-year interval of the study to 138 per
100,000 in the last interval. The annual incidence of
symptomatic stones did not increase significantly in either
men or women. There was, however, a significant increase in
the annual incidence of asymptomatic stones over time, from
7 to 24 per 100,000 for men and from 7 to 21 per 100,000 for
women. The increase in the incidence of asymptomatic
stones was only significant for women above 50 years of age
and for men older than 40 years. Thus, we found a significant
increase in the incidence of kidney stone disease resulting
from increased detection of asymptomatic stones. This was
largely due to a more frequent use of high-resolution
imaging studies in older patients.
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Kidney stone disease is a common health disorder in the
Western world with a reported lifetime prevalence of
10–12% in men and 5–6% in women.1–3 This disorder
causes significant morbidity among affected patients and
substantial financial burden to the society because of lost
work days and health-care costs. The prevalence of
calcium stones, the most common type of kidney stones,
varies considerably between different ethnic groups and
geographical areas, with the highest reported prevalence in
Caucasian males.1,4 Epidemiologic studies have suggested
an association between calcium kidney stones and dietary
calcium, protein, or salt intake5–8 and warm climates.9,10
Furthermore, a strong evidence for genetic predisposition
to the pathogenesis of nephrolithiasis has also been
demonstrated.11–13
Numerous reports have suggested upward trends in the
incidence and prevalence of kidney stone disease in recent
decades.1,14–17 In contrast, a previous Icelandic study18 did
not find a significant increase in stone prevalence over the
years 1967–1991. Similar to many prior studies, it was
associated with methodological limitations, as it was based
on self-reported history of kidney stones and was therefore
subject to a recall bias. A recent population-based study from
Olmsted County, Minnesota,19 using International Classifi-
cation of Diseases (ICD) codes for identification of
symptomatic kidney stone cases, demonstrated relatively
stable incidence rates from 1970 to 2000. At the end of
the study period, there even appeared to be a downward
trend in the overall incidence of kidney stones. Thus, studies
examining trends in kidney stone disease have yielded
variable results, some of which may be explained by
differences in design.
Reliable information about the epidemiology of nephro-
lithiasis is important, as it may have clinical and economic
implications. To determine as accurately as possible the
recent trends in the incidence of kidney stone disease, we
conducted a nationwide study in Iceland that was designed to
identify virtually all known cases of kidney stones in the adult
population during the past three decades.
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RESULTS
Our search strategy identified a total of 8994 patients aged
18 years and above, by ICD codes (n¼ 4155), radiology codes
(n¼ 7116), or surgical procedure codes (n¼ 879) indicative
of kidney stone disease. The same individuals were frequently
identified by more than one coding system. After a thorough
review of medical records, we excluded from the analysis
2040 patients who did not have kidney stones (the majority
had other abdominal calculi or calcifications, most
commonly gallstones) or who were residents of other
countries. An additional 289 patients who had their first
documented kidney stone in 1983 or 1984 were excluded
because of incomplete coding during those years. Finally, 720
patients who carried a prior diagnosis of kidney stone disease
were excluded from the incidence calculations.
From 1985 to 2008, the number of incident patients with
kidney stones was 5945, of whom 3746 (63%) were men. The
patients were almost exclusively non-Hispanic Caucasians,
reflecting the ethnic composition of the Icelandic population.
The mean age (±s.d.) at diagnosis of kidney stones was
52.5±17.4 years for men and 48.9±19.1 years for women
(Po0.001). The clinical manifestations of the 5945 patients
are presented in Table 1. The majority of patients (81.2%)
were symptomatic when they were first diagnosed with
kidney stones, whereas 9.5% were asymptomatic. In 5.9% of
patients, it was not possible to determine whether stone-
related symptoms were present or not and records of
the stone event were not available for an additional 3.5%.
The annual incidence of kidney stone disease increased
significantly during the study period, both for the total study
population and for each gender (Figure 1). The incidence
rose from 108 per 100,000 in the first 5-year interval of the
study period to 138 per 100,000 in the last interval (Po0.001).
In men, the incidence increased from 136 per 100,000 in the
first interval to 163 per 100,000 in the last interval
(P¼ 0.031), and in women from 80 to 112 per 100,000 in
the same respective time intervals (Po0.001). Figure 2 shows
the trends in the incidence rates of symptomatic and
asymptomatic stones. For symptomatic stones, the annual
incidence rose from 130 to 140 per 100,000 in men (P¼ 0.66)
and from 73 to 91 per 100,000 in women (P¼ 0.13), and thus
did not reach statistical significance. The annual incidence of
asymptomatic stones increased significantly for both genders,
from 7 to 24 per 100,000 in men (Po0.001) and from 7 to 21
per 100,000 in women (Po0.001). These time trends were
similar when kidney stone cases with indeterminate clinical
symptoms or unavailable clinical data were counted with
Table 1 | Clinical manifestations of the 5945 incident kidney
stone patients
Symptomatic patients 4826 (81.2%)
Flank pain 3572 (60.4%)
Abdominal pain 294 (6.3%)
Hematuria 484 (34.1%)
Urinary tract infection 217 (7.0%)
Other 259 (26.9%)
Asymptomatic patients 565 (9.5%)
Symptoms indeterminate 350 (5.9%)
Data not available 204 (3.4%)
Some patients had more than one clinical manifestation associated with kidney
stones.
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Figure 1 |Annual incidence of kidney stones in all patients
and by gender in Iceland, 1985 to 2008.
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Figure 2 |Annual incidence of symptomatic and asymptomatic kidney stones in Iceland from 1985 to 2008, averaged for five time
intervals. (a) Men and (b) women.
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asymptomatic stone formers. The incidence trends varied
between age groups (Figure 3). There was a significant
increase in the incidence of symptomatic stones in the age
group of 18–29 years, in both men (Po0.001) and women
(P¼ 0.015), and an increase of borderline significance in
women aged 30–39 years (P¼ 0.052) (Figure 3a and b).
A significant decrease in incidence of symptomatic stones
was observed among men aged 40–49 years (Po0.001)
(Figure 3a) and in women above 70 years of age (P¼ 0.006)
(Figure 3b). For asymptomatic stones, the increase in
incidence was significant in both genders in the age groups
50 years and older, and also in men aged 40–49 years (Figure
3c and d). The male to female ratio averaged 1.72 and did not
change significantly during the study period. The ratio was
lowest in the younger age groups.
Figure 4 shows the time trends in the use of abdominal
and urological imaging techniques, as well as the incidence
of asymptomatic kidney stones per 1000 imaging studies.
A marked increase in the use of imaging studies during the
study period is apparent, beginning in the early 1990s when
the first private medical imaging clinic in the country
opened. The use of computed tomography increased steadily
throughout the study period, and the increase was most
pronounced in the last 5 years. The incidence of asympto-
matic kidney stones per 1000 imaging studies demonstrated
two peaks, the first in the early 1990s and the second one
around 2005, which was larger and coincided with the
increase in the use of computed tomography scanning.
Stone analysis was available for only 228 (3.8%) of the
incident patients. Of those, 81% had calcium oxalate stones,
11% had calcium phosphate stones, and 6.6% had uric acid
stones. Only two patients had cystine stones and one patient
had struvite stones.
The prevalence calculations were based on the 6045 patients,
3768 men and 2277 women, who were alive during the last time
interval of the study. The period prevalence of kidney stone
disease in 2005–2008 was 2.6%. The prevalence was 3.3% for
men and 2.0% for women, but increased significantly with
age in both genders and was 10.1% and 4.2% for men and
women older than 70 years, respectively (Figure 5).
DISCUSSION
This study shows a significant rise in the incidence of kidney
stone disease in both genders from 1985 to 2008. This finding
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Figure 3 |Annual incidence of symptomatic and asymptomatic kidney stones in men and women by age group in Iceland, from 1985 to
2008, averaged for five time intervals. (a) Symptomatic stones in men, (b) symptomatic stones in women, (c) asymptomatic stones in men and
(d) asymptomatic stones in women. Note the different scale of the y-axis in the 4 panels.
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Figure 4 |Time trends in the use of urological and abdominal
imaging studies in Iceland from 1985 to 2008, and the
frequency of asymptomatic kidney stones per 1000 imaging
studies. CT, computed tomography; IVP, intravenous
pyelography; KUB, kidney, ureter, and bladder x-ray.
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was primarily driven by an increase in the incidence of
asymptomatic kidney stones in both genders, primarily in
subjects over the age of 50 years. In addition, a significant
increase in the incidence of symptomatic stone disease was
observed in the age group of 18–29 years for both genders.
The prevalence of kidney stone disease at the end of the study
period was relatively low when compared with recent reports
from various populations.
The incidence of symptomatic stones in our study is
similar to that found in a recent retrospective study carried
out in a predominantly Caucasian population of Olmsted
County, Minnesota,19 in which ICD codes were used to
identify cases. In Olmsted County, the overall incidence of
symptomatic stones did not change significantly during the
period 1970–2000, whereas the rate declined for men and
increased for women.19 In comparison, our study showed
that the incidence rate of symptomatic stones in men leveled
off or even decreased during the last decade of the study,
whereas in women there was a rise in the incidence that did
not reach statistical significance. However, the incidence in
the youngest age group increased significantly for both
genders. A study carried out in the Auckland region in New
Zealand16 revealed a significant increase in the annual
incidence of symptomatic kidney stone disease from 1997
to 2007. The increase was most conspicuous in women,
which is consistent with the findings of the Olmsted County
study. Interestingly, the combined incidence of symptomatic
and asymptomatic stones at the end of the present study was
B140 per 100,000 per year, whereas the incidence of
symptomatic stones in the New Zealand and Olmsted
County studies was B130 per 100,000 population per year.
Two other studies using a different design have demonstrated
an increasing incidence of stone disease. A Japanese study,17
using a questionnaire mailed to all urology clinics in the
country, showed a substantial increase in the incidence of
symptomatic kidney stone disease, which doubled from 1965
to 2005. The study was limited by a low response rate
(35.3%) and an estimation of the nationwide incidence from
the number of available hospital beds. The other study
conducted in Germany14 was based on self-reported history
of kidney stones and demonstrated a significant increase in
the incidence of kidney stone disease. Collectively, these
epidemiologic studies suggest that the incidence of kidney
stone disease has increased in recent decades, particularly
in women. However, the present study and the one in
Olmsted County would suggest that in some commu-
nities the incidence rate may have plateaued. The variability
in incidence trends observed in recent epidemiologic
studies may be caused by methodological differences. Our
study differs from previous population-based investigations
of the incidence of kidney stones, as it was designed
to capture all cases of both symptomatic and asympto-
matic stones.
The incidence of asymptomatic kidney stones in our study
tripled in both genders but this increase was only observed in
women older than 50 years and in men older than 40 years.
In fact, asymptomatic stones explained most of the rise in the
incidence of kidney stones in both men and women. The
increase in the incidence of asymptomatic kidney stones
appears to be the result of a greater availability of imaging
studies and a more common use of high-resolution
abdominal imaging studies such as ultrasound and computed
tomography, especially in older patients. Several previously
published reports20–22 have described a 2–3% prevalence of
asymptomatic kidney stones in unselected populations
screened with renal ultrasound. A more recent study by
Bansal et al.23 identified kidney stones in 8.6% of patients
who had undergone abdominal or retroperitoneal ultrasound
examination, of whom at least 30% were asymptomatic.
Thus, asymptomatic kidney stones appear to be fairly
common, and some of these stones may become sympto-
matic later in life although their natural history has not been
well characterized. Our conclusion that the increased
incidence of asymptomatic kidney stones is explained
by greater use of high-resolution abdominal imaging studies
is in line with the findings of a recent Icelandic study
that found a highly significant rise in the incidental diagnosis
of renal cell carcinoma to be strongly associated with
increased use of abdominal ultrasound and computed
tomography scans.24
The male to female ratio of B1.7 did not change
significantly over time and is similar to what we have
previously observed in the adult Icelandic population18 but
significantly lower than the ratio of 2–3:1 reported by other
investigators.1,3,25 However, a decline in the male to female
ratio was found in the Olmsted County and New Zealand
studies.16,19 Hence, kidney stone disease appears to be
becoming more common in women, particularly in the
younger age groups.
The explanation for a rising incidence of symptomatic
kidney stone disease in recent decades remains to be
elucidated. Changes in lifestyle and dietary factors, such as
increased consumption of animal protein and salt7 and
decreased consumption of calcium-rich dairy products,5,26
have been implicated as risk factors. Increasing prevalence of
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Figure 5 |Age-specific period prevalence of kidney stone
disease in Iceland from 2005 to 2008.
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common comorbid conditions associated with kidney stones,
including obesity27 and metabolic syndrome,28 may also have
a role. Finally, recent reports9,29 suggest that climate changes
associated with global warming may contribute to increasing
rates of kidney stone formation.
Recent studies have also shown an increase in the
prevalence of kidney stones. A large study based on data
from the United States National Health and Nutrition
Examination Surveys I and II1 demonstrated a 37% increase
in the prevalence of kidney stones in Caucasians, between the
years 1976–1980 and 1988–1994. The increase in prevalence
was most pronounced in the oldest age groups for both
genders. Two Italian studies15,30 also showed a similar rise in
the prevalence of kidney stones in the 1980s and early 1990s.
All these studies were based on a self-reported history of
kidney stone disease. The design of our study did not allow
the assessment of changes in prevalence of kidney stone
disease over time. The 3.2% prevalence of stones in men and
2.0% in women observed during the last 4 years of the study
is lower than the crude self-reported prevalence of 4.3% in
men and 3.0% in women previously reported by our group,18
and is also substantially lower than the prevalence rates
reported by other investigators in recent years.1,14 It should,
however, be noted that the design of the present study results
in an underestimation of the true prevalence of nephro-
lithiasis, as we did not capture patients who had their first
documented kidney stone before the year 1985 and remained
free of recurrence during the entire study period. Never-
theless, we believe that our prevalence data reflect the scope
of active kidney stone disease in Iceland. Many of the more
recent studies have been based on a self-reported history of
kidney stones and are, therefore, subject to a recall bias. In
contrast, the present study only includes confirmed cases of
stone disease, identified by a stringent medical record review
using a strategy that is superior to most of the prior work in
this field. It is also noteworthy that we observed a prevalence
of 10.1% in men in the age group above 70 years, which
is comparable to the lifetime prevalence reported by
others.1,14,15,31
Analysis of stone composition was rarely carried out in
our patient sample. Nevertheless, our limited data showed
the composition of kidney stones to be consistent with
findings reported in other populations.
The main strength of our study is the population-based
design with the inclusion of practically all patients diagnosed
with kidney stones in Iceland during the study period. The
Icelandic population bears many similarities to other Western
nations, and we believe that our data can be viewed as fairly
representative for Western populations in general. The
Icelandic population is primarily Caucasian with a genetic
background, which is a relatively homogenous mixture of
alleles from the British Isles and Scandinavia, reflecting the
gene pool of Northern Europeans over 1000 years ago.32 The
lifestyle is comparable to other affluent industrialized
countries, including dietary habits,33 and there has been a
marked increase in mean body mass index, and the
prevalence of obesity and type 2 diabetes in Iceland over
the past three decades.34 The robust methodology, including
the highly sensitive search strategy and meticulous review of
medical records of all patients suspected of kidney stone
disease, as well as the differentiation of symptomatic from
asymptomatic stones, makes this study unique compared
with previous work in this field. Finally, we believe that
incidence, the main focus of our study, may be a more
accurate measure of active stone disease than prevalence,
reported in the majority of epidemiological studies of kidney
stone disease to date.
The study does have some limitations inherent in the
retrospective design. Despite the inclusion of a large number
of subjects and a probable capture rate in excess of 95% of
Icelandic patients diagnosed with symptomatic kidney stones
during the study period, our results probably underestimate
the true incidence as individuals with mild or short-lived
symptoms may not have sought medical care or may have
been treated by their primary care physician without
obtaining an imaging study. A false-positive detection of
kidney stones may have occurred in occasional cases.
However, we believe it is very unlikely that this has
significantly affected our results as the rate of false-positive
stone detection by ultrasound is very low,35 and computed
tomography is now the preferred imaging study for the
diagnosis of kidney stones.
In summary, the incidence of kidney stone disease in
Iceland is similar or slightly higher than incidence rates
recently reported in a number of other populations around
the globe. A significant increase in the incidence of kidney
stone disease occurred in both men and women from 1985 to
2008. The rise in incidence was primarily because of an
increase in asymptomatic kidney stones in subjects over the
age of 50 and symptomatic stone disease in the age group of
18–29 years. The increased incidence of asymptomatic stones
in older patients is likely due to an increased detection
resulting from a more frequent use of high-resolution
abdominal imaging studies in this age group. Changes
in diet and lifestyle may explain the rising incidence rate
of symptomatic kidney stones but this notion requires
further study.
MATERIALS AND METHODS
Study design and setting
This was a retrospective population-based study of adult (age 18 years
or older) patients diagnosed with kidney stones in Iceland during the
period 1983–2008. The study was approved by the National Bioethics
Committee (NBC 03-002-S1-AG1) and the Icelandic Data Protection
Authority. Computerized databases of all major hospitals and medical
imaging centers in Iceland were searched for diagnostic and surgical
procedure codes indicative of kidney stones. Electronic recording of
diagnostic codes was introduced in 1983. Patients with a first stone
recorded before 1985 were excluded from the incidence analysis
because of incomplete electronic coding of health records during 1983
and 1984.
Participating institutions included the following: Landspitali – The
National University Hospital of Iceland in Reykjavik, a community
150 Kidney International (2012) 83, 146–152
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hospital for half of Iceland’s population and a tertiary care center
for the whole nation; Akureyri Hospital in North Iceland, the
largest hospital outside the Reykjavik area; and Domus Radiology
in Reykjavik, the largest privately operated medical imaging clinic
in the country. These institutions conducted over 95% of all
abdominal and urinary tract imaging studies in the country and
close to 100% of surgical procedures for kidney stone disease during
the study period.
Patient search strategy and characterization
To identify kidney stone patients, we searched for the ICD codes,
radiology diagnosis codes, and surgical procedure codes listed below.
1. ICD codes:
ICD-9 codes 592.0 (calculus of kidney), 592.1 (calculus of
ureter), 592.9 (calculus of urinary tract, unspecified), 270.0
(cystinuria), and 271.8 (primary hyperoxaluria). ICD-10 codes
N20.0 (calculus of kidney), N20.1 (calculus of ureter), N20.2
(calculus of kidney with calculus of ureter), N20.9 (urinary calculus,
unspecified), N21.0 (calculus in bladder), N21.1 (calculus
in urethra), N21.8 (other lower urinary tract calculus), N21.9
(calculus of lower urinary tract, unspecified), N22.0 (urinary
calculus in schistosomiasis), N22.8 (calculus of urinary tract in
other diseases classified elsewhere), E72.0 (cystinuria), E74.8
(primary hyperoxaluria), and E79.8 (xanthine and 2,8–dihydro-
xyadenine stones).
2. Radiology diagnosis codes:
460.812 (plain x-ray of the abdomen showing calcification(s)),
501.812 (plain x-ray of the urinary tract showing calcification(s)),
510.812 (intravenous pyelography showing calcifications/stones),
940.812 (abdominal ultrasound study showing calcifications/
stones), 950.812 (renal ultrasound study showing calcifications/
stones), 840.812 (computed tomography of the abdomen with
calcification(s)), and 850.812 (computed tomography of the kidneys
with calcification(s)).
3. Nordic Classification of Surgical Procedures codes:
KAE 00 (nephrolithotomy), KAE 01 (nephroscopic nephrolitho-
tomy), KAE 10 (pyelolithotomy), KAE 11 (nephroscopic pyelo-
lithotomy), KAE 12 (retrograde ureteronephroscopic lithotripsy in
pelvis of kidney), KAE 96 (other removal of calculus from kidney
or pelvis of kidney), KAE 97 (other percutaneous endosopic
removal of calculus from kidney or pelvis of kidney), KAE 98
(other transluminal endosopic removal of calculus from kidney or
pelvis of kidney), KBE 00 (ureterolithotomy), KBE 01 (percutaneous
endoscopic ureterolithotomy), KBE 12 (transluminal endoscopic
extraction of calculus of ureter), KBE 22 (transluminal endoscopic
dislodgement of impacted calculus from ureter), KBE 96 (other
operation for calculus of ureter), KBE 97 (other percutaneous
endoscopic operation for calculus of ureter), KBE 98 (other
transluminal endoscopic operation for calculus of ureter), KCE 00
(cystolithotomy), KCE 01 (percutaneous endoscopic extraction of
calculus from bladder), KCE 02 (transluminal endoscopic extraction
of calculus from bladder), KAT 00 (extracorporeal shock wave
lithotripsy (ESWL) of pelvis of kidney), KBT 00 (ESWL of ureter),
and KCT 00 (ESWL of bladder).
To confirm the diagnosis of kidney stone disease, a thorough
medical record review was conducted for all patients identified by
our search strategy. Information on clinical manifestations asso-
ciated with kidney stones, prior history of nephrolithiasis, and stone
analysis was obtained from medical records. In addition, radiology
reports were carefully reviewed with respect to information on
clinical history and the result of the imaging study, both of which
were used for confirmation or exclusion of kidney stone disease.
If calcifications were noted in the radiology report, an attempt was
made to differentiate kidney stones from vascular and other visceral
calcifications, gallstones, and phleboliths. Patients with calcifications
other than kidney stones were excluded from the study. Incident
kidney stone disease was classified as symptomatic or asymptomatic.
Patients were considered symptomatic if they had flank or
abdominal pain, hematuria, urinary tract infection, or other
manifestations suggestive of kidney stones. Cases were classified as
indeterminate if the clinical information was insufficient to reliably
determine whether patients were symptomatic, and as data not
available if records of the incident kidney stone could not be located.
For the data analysis, indeterminate cases and those for whom data
were not available were considered symptomatic.
Statistical analysis
Incidence and prevalence were calculated for both genders based on
the size of the Icelandic population aged 18 years or older, which was
238,587 at the end of the study period (31 December 2008, http://
www.statice.is/Statistics/Population/Overview). For the analysis, the
study period was divided into five intervals, 1985–89, 1990–94,
1995–99, 2000–04, and 2005–08 and the patients were divided into six
age groups, 18–29, 30–39, 40–49, 50–59, 60–69, and 470 years. We
calculated the crude incidence of kidney stone disease and the
incidence according to age and gender. The two-sample t-test was used
to compare men and women with respect to age. Time trends in stone
incidence were assessed by Poisson regression analysis. Period
prevalence was calculated for the last 4 years of the study and was
based on all known patients with a history of kidney stone disease who
were alive during this time interval. Statistical analysis was performed
with the computer software SPSS version 11 (SPSS, Chicago, IL).
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